Muyan Cai Selected Research

Muyan Cai Research Topics

Disease

19	Neoplasms (Cancer) 10/2022 - 04/2011
9	Hepatocellular Carcinoma (Hepatoma) 10/2021 - 01/2012
5	Carcinoma (Carcinomatosis) 09/2021 - 04/2011
5	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 03/2016
4	Neoplasm Metastasis (Metastasis) 09/2021 - 03/2014
3	Carcinogenesis 12/2017 - 01/2012
2	Esophageal Squamous Cell Carcinoma 08/2021 - 11/2015
2	Fibrosis (Cirrhosis) 03/2017 - 01/2013
2	Necrosis 02/2015 - 01/2013
1	Urachal cancer 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Nasopharyngeal Carcinoma 12/2017
1	Chromosomal Instability (Chromosome Stability) 12/2017
1	Inflammation (Inflammations) 12/2017
1	Malignant Mesothelioma 01/2017
1	Adenocarcinoma 06/2016
1	Pathologic Complete Response 06/2016
1	Endometrial Neoplasms (Endometrial Cancer) 08/2014
1	Lymphoma (Lymphomas) 08/2014
1	Genomic Instability 04/2013
1	Infarction (Infarctions) 01/2013
1	Heart Failure 01/2013
1	Cardio-Renal Syndrome 01/2013
1	Liver Neoplasms (Liver Cancer) 09/2012
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2012
1	Cystadenoma 04/2011

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 12/2017 - 04/2011
6	Biomarkers (Surrogate Marker)IBA 10/2021 - 04/2011
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
3	Messenger RNA (mRNA)IBA 10/2014 - 04/2013
2	Cadherins (E-Cadherin)IBA 09/2021 - 03/2014
2	MicroRNAs (MicroRNA)IBA 05/2018 - 08/2014
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2021
1	KinesinsIBA 10/2021
1	CateninsIBA 10/2021
1	Capsules (Microcapsules)IBA 08/2021
1	130-nm albumin-bound paclitaxelIBA 08/2021
1	camrelizumabIBA 08/2021
1	Aldehyde DehydrogenaseIBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	EnzymesIBA 05/2018
1	Biological ProductsIBA 01/2018
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2018
1	Phosphoglycerate Mutase (Phosphoglyceromutase)IBA 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 12/2017
1	Mitochondrial DNA (mtDNA)IBA 12/2017
1	Surface Antigens (Surface Antigen)IBA 03/2017
1	AfatinibIBA 01/2017
1	CrizotinibIBA 01/2017
1	AsbestosIBA 01/2017
1	Carrier Proteins (Binding Protein)IBA 01/2017
1	ElementsIBA 01/2017
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2017
1	endonuclease GIBA 04/2016
1	K Cl- CotransportersIBA 04/2016
1	Apoptosis Inducing FactorIBA 04/2016
1	Metalloproteases (Metalloproteinases)IBA 04/2016
1	Fibronectins (Fibronectin)IBA 04/2016
1	HexokinaseIBA 03/2016
1	PhosphoproteinsIBA 02/2015
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 02/2015
1	Receptor-Interacting Protein Serine-Threonine KinasesIBA 02/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 08/2014
1	Cysteine (L-Cysteine)FDA Link 08/2014
1	Cysteine-Rich Protein 61IBA 08/2014
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2014
1	Estrogens (Estrogen)FDA Link 04/2014
1	Transcription Factors (Transcription Factor)IBA 04/2014
1	Small Interfering RNA (siRNA)IBA 03/2014
1	CyclinsIBA 04/2013
1	Ligases (Synthetase)IBA 04/2013
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2013
1	UbiquitinIBA 04/2013
1	NitrogenIBA 01/2013
1	CreatinineIBA 01/2013
1	Urea (Carbamide)FDA LinkGeneric 01/2013
1	Angiotensin IIIBA 01/2013
1	Losartan (Cozaar)FDA LinkGeneric 01/2013
1	Type 1 Angiotensin ReceptorIBA 01/2013
1	Angiotensin II Type 1 Receptor BlockersIBA 01/2013
1	Cystatin CIBA 01/2013
1	Histone MethyltransferasesIBA 09/2012
1	histone H3 trimethyl Lys4IBA 09/2012
1	Histones (Histone)IBA 09/2012
1	Lysine (L-Lysine)FDA Link 09/2012
1	Fetal Proteins (Fetoprotein)IBA 01/2012
1	Phosphotransferases (Kinase)IBA 01/2012
1	SirtuinsIBA 01/2012
1	Sirtuin 3IBA 01/2012
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2012
1	NAD (NADH)IBA 01/2012
1	Adenine NucleotidesIBA 01/2012
1	ParaffinIBA 04/2011

Therapy/Procedure

6	Immunotherapy 10/2022 - 01/2021
4	Therapeutics 01/2019 - 08/2014
2	Drug Therapy (Chemotherapy) 08/2021 - 01/2018
2	Esophagectomy 08/2021 - 11/2015
2	Neoadjuvant Therapy 06/2016 - 11/2015
1	VAP-cyclo protocol 01/2012